Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireDecember 10, 2024
Press ReleaseDistrict neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism SHENZHEN, China, Dec. 10, 2024 /PRNewswire/ — Luohu district of Shenzhen, an… CISION PRNewswireDecember 10, 2024
Press ReleaseNoah Holdings 2024 Corporate Open Day: Driving Global Expansion and Sophisticated Solutions for Mandarin-Speaking Clients SHANGHAI, Dec. 10, 2024 /PRNewswire/ — Noah Holdings recently hosted its 2024 Corporate… CISION PRNewswireDecember 10, 2024
LifestylePress ReleaseInfinix Introduces Vibrant New Colors for the HOT 50 Series: A Bold Lifestyle Statement for the New Year HONG KONG, Dec. 10, 2024 /PRNewswire/ — Infinix, a trendy tech brand crafted… CISION PRNewswireDecember 10, 2024
Press ReleaseIntroducing the Gianna Lullume Smart Infant Sleep Device: A Revolutionary Solution for Infant Sleep Now on Kickstarter HONG KONG, Dec. 10, 2024 /PRNewswire/ — The Gianna Lullume Smart Infant Sleep… CISION PRNewswireDecember 10, 2024
Recurrent Energy Signs 300 MW Power Purchase Agreement with Major U.S. Tech Company in Spain KITCHENER, ON, Dec. 10, 2024 /PRNewswire/ — Recurrent Energy, a subsidiary of Canadian… CISION PRNewswireDecember 10, 2024
Syntara announces positive interim data in Phase 2 study of SNT-5505 in myelofibrosis SYDNEY, Dec. 10, 2024 /PRNewswire/ — Syntara Limited (ASX:SNT), a clinical-stage drug… CISION PRNewswireDecember 10, 2024
Press ReleaseSurplusGLOBAL to Participate in SEMICON JAPAN 2024, Showcasing AI-Based 'SemiMarket' and Legacy Equipment Solutions SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ — SurplusGLOBAL will participate in… CISION PRNewswireDecember 10, 2024
